Experience EOSTM
in Action

ArtVentive has developed the Endoluminal Occlusion System (EOSTM), capable of achieving immediate, complete, and permanent occlusion of peripheral vasculature.

About ArtVentive

About ArtVentive

Learn more about the team behind our innovative success

Meet EOS


View the device that redefines
peripheral embolization

Case Studies

Case Studies

Explore our case studies to see how our products are improving clinical outcomes

News and Events

Evaluation of Effectiveness of Embolization in Pelvic Congestion Syndrome with the New Vascular Occlusion Device (ArtVentive EOS™): Preliminary Results

Successful embolization procedures with ArtVentive EOS™. This study aimed to collect confirmatory data in support of the safety and efficiency of the ArtVentive EOS™ for the treatment of the pelvic congestion syndrome (PCS). A decrease in pelvic pain intensity based on the VAS was considered a clinical success. Read More.

ArtVentive Launches U.S. commercialization by Showcasing its EOS™ Device at GEST-2016. May 2016, New York

ArtVentive Medical Group, Inc. commenced the launch of its flagship occlusion device product, the ArtVentive Endoluminal Occlusion System (EOS™) at the Global Embolization Symposium and Technologies (GEST) in New York, NY on May 5-8. The introduction in the United States follows the initial commercialization in the E.U. last year. Read More.

Visit ArtVentive at GEST 2016

Join us at the ArtVentive Booth #28 to learn more about the EOS™ Endoluminal Occlusion System at the GEST 2016 U.S. conference in New York. Conference Dates: 05/05/16 – 05/08/16. Read More.